Details for New Drug Application (NDA): 203856
✉ Email this page to a colleague
The generic ingredient in CYCLOPHOSPHAMIDE is cyclophosphamide. There are nineteen drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the cyclophosphamide profile page.
Summary for 203856
Tradename: | CYCLOPHOSPHAMIDE |
Applicant: | Hikma |
Ingredient: | cyclophosphamide |
Patents: | 0 |
Pharmacology for NDA: 203856
Mechanism of Action | Alkylating Activity |
Medical Subject Heading (MeSH) Categories for 203856
Suppliers and Packaging for NDA: 203856
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CYCLOPHOSPHAMIDE | cyclophosphamide | CAPSULE;ORAL | 203856 | NDA | Hikma Pharmaceuticals USA Inc. | 0054-0382 | 0054-0382-25 | 100 CAPSULE in 1 BOTTLE (0054-0382-25) |
CYCLOPHOSPHAMIDE | cyclophosphamide | CAPSULE;ORAL | 203856 | NDA | Hikma Pharmaceuticals USA Inc. | 0054-0383 | 0054-0383-25 | 100 CAPSULE in 1 BOTTLE (0054-0383-25) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 25MG | ||||
Approval Date: | Sep 16, 2013 | TE: | AB | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 50MG | ||||
Approval Date: | Sep 16, 2013 | TE: | AB | RLD: | Yes |
Complete Access Available with Subscription